Ginkgo Bioworks Holdings, Inc. Research And Development Expense

Quick Answer

Ginkgo Bioworks Holdings, Inc. reported Research And Development Expense of $243.77 million for the year ending 2025.

  • Ginkgo Bioworks Holdings, Inc. showed a decrease of -42.5% in Research And Development Expense from 2024 to 2025.
  • This data is from Ginkgo Bioworks Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Ginkgo Bioworks Holdings, Inc.'s Research And Development Expense has grown by 153.1%.
  • Historical annual values: Fiscal year 2025: $243.77 million | Fiscal year 2024: $424.06 million | Fiscal year 2023: $580.62 million | Fiscal year 2022: $1.05 billion | Fiscal year 2021: $1.15 billion | Fiscal year 2020: $159.77 million | Fiscal year 2019: $96.30 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: